CSIMarket
 


United Cannabis Corp  (CNAB)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

United Cannabis's Working Capital Ratio

CNAB's quarterly Working Capital Ratio and Current Assets, Current Liabilities growth




CNAB Working Capital Ratio (Sep 30 2019)
III. Quarter
(Jun 30 2019)
II. Quarter
(Mar 31 2019)
I. Quarter
(Dec 31 2018)
IV. Quarter
(Sep 30 2018)
III. Quarter
Y / Y Current Liabilities Change 376.07 % 183.78 % 552.2 % 373.63 % 214.7 %
Y / Y Current Assets Change -60.81 % 76.79 % 421.03 % 293.59 % 324.58 %
Working Capital Ratio MRQ 0.09 0.45 0.32 0.63 1.13
Overall Ranking # # # # #
Seq. Current Liabilities Change 46.79 % 51.7 % 7.44 % 98.99 % -12.5 %
Seq. Current Assets Change -69.5 % 111.45 % -45.11 % 10.71 % 37.59 %



Working Capital Ratio third quarter 2019 Comment
Due to increase in Current Liabilities in the third quarter 2019, Working Capital Ratio fell to 0.09 below United Cannabis Corp average.

Within Biotechnology & Drugs industry 179 other companies have achieved higher Working Capital Ratio than United Cannabis in third quarter 2019. While total ranking remained unchanged compare to previous quarter at no. .

Explain Working Capital Ratio
Where is CNAB most successful ?
Working Capital Ratio CNAB on the trailing twelve month basis
Working Capital Ratio third quarter 2019 Company Ranking
Within: No.
Biotechnology & Drugs Industry # 180
Healthcare Sector # 717
Overall Market # 4263


Working Capital Ratio Statistics
High Average Low
129.87 6.31 0.02
(Mar 31 2014)   (Jun 30 2016)




Financial Statements
United Cannabis's Current Liabilities $ 13 Millions Visit CNAB's Balance sheet
United Cannabis's Current Assets $ 1 Millions Visit CNAB's Balance sheet
Source of CNAB's Sales Visit CNAB's Sales by Geography




Companies with similar Working Capital Ratio in the quarter endingSep 30 2019, within Biotechnology & Drugs Industry Working Capital RatioSep 30 2019 MRQ Current AssetsSep 30 2019 MRQ Current Liabilities
Cardax, Inc.  0.23 $ 1.665  Millions$ 7.289  Millions
Burzynski Research Institute Inc  0.20 $ 0.046  Millions$ 0.229  Millions
Twinlab Consolidated Holdings, Inc.  0.19 $ 22.618  Millions$ 121.656  Millions
Qrons Inc.  0.17 $ 0.080  Millions$ 0.460  Millions
Petvivo Holdings, Inc.  0.17 $ 0.185  Millions$ 1.072  Millions
Cytodyn Inc.  0.14 $ 3.200  Millions$ 23.067  Millions
Artemis Therapeutics, Inc.  0.13 $ 0.020  Millions$ 0.156  Millions
Quest Patent Research Corp  0.12 $ 0.889  Millions$ 7.583  Millions
Q Biomed Inc.  0.12 $ 0.330  Millions$ 2.859  Millions
Predictive Oncology Inc.  0.10 $ 1.063  Millions$ 10.782  Millions
United Cannabis Corp  0.09 $ 1.242  Millions$ 13.374  Millions
Gtx Corp  0.09 $ 0.326  Millions$ 3.774  Millions
Premier Biomedical Inc  0.08 $ 0.178  Millions$ 2.304  Millions
Therapeutic Solutions International, Inc.  0.07 $ 0.145  Millions$ 1.960  Millions
Sangui Biotech International Inc  0.06 $ 0.041  Millions$ 0.634  Millions
Boston Therapeutics, Inc.  0.05 $ 0.339  Millions$ 6.362  Millions
Oncbiomune Pharmaceuticals, Inc  0.03 $ 0.378  Millions$ 14.090  Millions
Mateon Therapeutics Inc  0.03 $ 0.071  Millions$ 2.690  Millions
U.s. Stem Cell, Inc.  0.02 $ 0.183  Millions$ 8.934  Millions


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

SALT's Profile

Stock Price

SALT's Financials

Business Description

Fundamentals

Charts & Quotes

SALT's News

Suppliers

SALT's Competitors

Customers & Markets

Economic Indicators

SALT's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071